09:39 AM EST - IMV Inc. : Announced the drawdown of the remaining $10 million U.S. available under its existing $25-million U.S. debt facility led by Horizon Technology Finance Corporation. This drawdown has been made available as the Company achieved a predetermined milestone following site activation in its Phase 2b AVALON trial in platinum-resistant ovarian cancer. IMV Inc.
shares T.IMV are trading unchanged at $0.92.
